Literature DB >> 15149177

3'-methylphosphonate-modified oligo-2'-O-methylribonucleotides and their Tat peptide conjugates: uptake and stability in mouse fibroblasts in culture.

Chrissy E Prater1, Paul S Miller.   

Abstract

Antisense oligo-2'-O-methylribonucleotides and their methylphosphonate derivatives show high binding affinities for their complementary targets under essentially physiological conditions. Additionally, the methylphosphonate linkage is resistant to nuclease hydrolysis. Here we show that a single methylphosphonate internucleotide linkage at the 3'-end of an oligo-2'-O-methylribonucleotide is sufficient to prevent degradation by the 3'-exonuclease activity found in mammalian serum. Complexes formed between a cationic lipid, Oligofectamine, and 5'-[(32)P]-labeled methylphosphonate modified oligo-2'-O-methylribonucleotides are taken up by mouse L(929) fibroblasts in culture. The extent of uptake appears to be dependent upon the sequence of the oligonucleotide. Examination of lysates of oligonucleotide treated cells by polyacrylamide gel electrophoresis showed that no degradation of the oligonucleotide occurred, even after incubation for 24 h. A fluorescein-derivatized oligomer was shown to localize mainly in the cell nucleus as monitored by fluorescence microscopy. Covalent conjugates of fluorescein-derivatized 3'-methylphosphonate modified oligo-2'-O-methylribonucleotides with Tat peptide, a cell permeating peptide, were also prepared. The Tat peptide was coupled to the 5'-end of the oligonucleotide using either disulfide coupling chemistry or conjugation of a keto derivative of the Tat peptide via a 4-(2-aminooxyethoxy-2-(ethylureido)quinoline group at the 5'-end of the oligonucleotide. Although formation of the Tat peptide conjugates was confirmed by mass spectrometry, the propensity of these oligonucleotides to form aggregates and their apparent high affinity for plastic and glass made the conjugates unsuitable for studies of uptake by cells in culture.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15149177     DOI: 10.1021/bc049977+

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  8 in total

1.  Inhibition of transcription by platinated triplex-forming oligonucleotides.

Authors:  Mindy K Graham; Paul S Miller
Journal:  J Biol Inorg Chem       Date:  2012-09-11       Impact factor: 3.358

2.  Chimeric RNase H-competent oligonucleotides directed to the HIV-1 Rev response element.

Authors:  Chrissy E Prater; Anthony D Saleh; Maggie P Wear; Paul S Miller
Journal:  Bioorg Med Chem       Date:  2007-06-02       Impact factor: 3.641

3.  An Amphipathic trans-Acting Phosphorothioate DNA Element Delivers Uncharged PNA and PMO Nucleic Acid Sequences in Mammalian Cells.

Authors:  Harsh V Jain; Serge L Beaucage
Journal:  Curr Protoc Nucleic Acid Chem       Date:  2016-03

4.  Synthesis, cellular uptake and HIV-1 Tat-dependent trans-activation inhibition activity of oligonucleotide analogues disulphide-conjugated to cell-penetrating peptides.

Authors:  John J Turner; Andrey A Arzumanov; Michael J Gait
Journal:  Nucleic Acids Res       Date:  2005-01-07       Impact factor: 16.971

5.  Subnanomolar antisense activity of phosphonate-peptide nucleic acid (PNA) conjugates delivered by cationic lipids to HeLa cells.

Authors:  Takehiko Shiraishi; Ramin Hamzavi; Peter E Nielsen
Journal:  Nucleic Acids Res       Date:  2008-07-02       Impact factor: 16.971

6.  Innovative developments and emerging technologies in RNA therapeutics.

Authors:  François Halloy; Annabelle Biscans; Katherine E Bujold; Alexandre Debacker; Alyssa C Hill; Aurélie Lacroix; Olivia Luige; Roger Strömberg; Linda Sundstrom; Jörg Vogel; Alice Ghidini
Journal:  RNA Biol       Date:  2021-12-31       Impact factor: 4.652

7.  Efficient Synthesis of 2'-O-Methoxyethyl Oligonucleotide-Cationic Peptide Conjugates.

Authors:  François Halloy; Alyssa C Hill; Jonathan Hall
Journal:  ChemMedChem       Date:  2021-09-08       Impact factor: 3.540

Review 8.  Aptamers Chemistry: Chemical Modifications and Conjugation Strategies.

Authors:  Fadwa Odeh; Hamdi Nsairat; Walhan Alshaer; Mohammad A Ismail; Ezaldeen Esawi; Baraa Qaqish; Abeer Al Bawab; Said I Ismail
Journal:  Molecules       Date:  2019-12-18       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.